期刊文献+

Neurturin基因的克隆及其在Vero细胞中的表达 被引量:1

Cloning of Neurturin Gene and Its Expression in Vero Cells
下载PDF
导出
摘要 目的克隆Neurturin(NTN)基因,并在Vero细胞中表达。方法用RT-PCR方法扩增hNTN cDNA,并克隆至pcDNA3真核表达载体中,经Lipofectamine2000转染Vero细胞,挑选稳定表达克隆,用RT-PCR及免疫荧光分析鉴定,并对转染后细胞的形态及生长状况进行分析。结果重组质粒pcDNA3/hNTN转染Vero细胞后获得了稳定表达克隆,且有目的蛋白表达,转染后细胞形态和生长特性发生了一定改变。结论获得了稳定表达NTN蛋白的Vero细胞株,为其移植并进行帕金森病猴基因治疗动物实验奠定了基础。 Objective To clone Neurturin (NTN) gene and express in Vero cells.Methods Amplify human NTN eDNA by RT-PCR and clone to eurkaryotie expression vector peDNA3. Transfect Vero cells with the constructed recombinant plasmid peDNA3/hNTN in mediation of Lipofectamine 2000. Identify the expressed product by RT-PCR and IFA. Observe the morphology and growth of transfected Vero cells. Re- sults The positive clones for stable expression of NTN was obtained after transfection of Vero cells with recombinant plasmid peDNA3/hNTN, and the target protein was expressed. The morphology and growth of transfected Vero cells showed significant change. Conclusion The Vero cell strain for stable expression of NTN was established, which laid a foundation of gene therapy of Parkinson disease in rhesus.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第4期265-268,共4页 Chinese Journal of Biologicals
基金 云南省科技强省计划基础研究重点项目(2007C0012Z)
关键词 Neurturin基因 VERO细胞 克隆 表达 帕金森病 Neurturin gene Vero cells Cloning Expression Parkinson disease
  • 相关文献

参考文献7

  • 1Lang AE, Miyasaki J, Olanow CW, et al. Progress in clinical neurosciences: a forum on the early management of Parkinson' s disease. Can J Neurol Sci, 2005,32 ( 3 ) : 277-286.
  • 2Perlmutter JS, Mink JW. Deep brain stimulation. Annu Rev Neurosci, 2006,29:229-257.
  • 3Lin LF, Doherty DH, Lile JD, et al. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 1993, 260 (5) : 1130-1132.
  • 4Kotzbauer PT, Lampe PA, Heuckeroth RO, et al. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature, 1996, 384 ( 6608 ) : 467-470.
  • 5Bartus RT, Herzog CD, Cunningham JJ, et al. Biological activity of CERE-120,an AAV-2 vector encoding human neurturin,in the rat 6-hydroxydopamine model of nigrostriatal degeneration and in the young intact and aged rat. Society for Neuroscience Annual Meeting, Washington D C. 2005.
  • 6Li H, He Z, Su T, et al. Protective action of recombinant neurturin on dopaminergic neurons in substanfia nigra in a rhesus monkey model of Parkinson's disease. Neurol Res, 2003,25 ( 3 ) : 263-267.
  • 7Kordower JH, Herzog CD, Dass B, et al. Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys. Ann Neurol,2006,60(6) :706-715.

同被引文献11

  • 1Meleh M, Pozlep B, Mlakar A, et al. Determination of serum lysophosphatidic acid as a potential biomarker for ovarian cancer [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2007, 858 ( 1/2): 287-291.
  • 2Pua TL, Wang FQ, Fishman DA, et al. Roles Of LPA in ovarian cancer development and progression [J]. Future Oncol, 2009, 5( 10): 1659-1673.
  • 3EI Touny LH, Banerjee PP. et al. Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis [J]. Cancer Res, 2009, 69 (8): 3695-3703.
  • 4Sengupta S, Kim KS, Berk MP, et al. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion [J]. Oncogene, 2007, 26(20): 2894-2901.
  • 5Hurst JH, Mendpara N, Hooks SB. Regulator of G-protein signalling expression and function in ovarian cancer cell lines [J]. Cell Mol Biol Lett, 2009, 14 (1): 153-174.
  • 6Fei Y, Cheng Z, Liu S, et al. Expression and clinical significance of p120 catenln mRNA and protein in pancreatic carcinoma [J]. Bosn J Basic Med Sci, 2009, 9 (3):191-197.
  • 7Larive RM, Urbach S, Poncet J, et al. Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell- cell adhesion [Jj. Oncogenc, 2009, 28 (24): 2337-2347.
  • 8Zeng Y, Abdallah A, Lu JP, et al. Delta-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles [J]. Mol Cancer, 2009, 8 (1): 19.
  • 9Williams NK, Lucet IS, Klinken SP, et al. Crystal structures of the Lyn protein tyrosine kinase domain in its Apo- and inhibitor- bound state [J]. J Biol Chem, 2009, 284 (1): 284-291.
  • 10Huang RY, Wang SM, Hsieh CY, et al. Lysophosphatidic acid induces ovarian cancer cell dispersal by activating Fyn kinase associated with p120-catenin [J]. Int J Cancer, 2008, 123(4): 801- 809.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部